Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Revenue        
Product sales, net $ 2,523,750 $ 2,371,710 $ 6,212,738 $ 5,836,196
Cost of products sold 873,586 789,801 2,275,871 2,157,990
Gross profit 1,650,164 1,581,909 3,936,867 3,678,206
Selling, general and administrative expenses 3,082,534 3,290,998 5,790,161 6,292,109
Research and development expenses 120,065 309,335 225,080 452,780
Total operating expenses 3,202,599 3,600,333 6,015,241 6,744,889
Loss from operations (1,552,435) (2,018,424) (2,078,374) (3,066,683)
Other (expenses) (1,024) (1,004) (1,763) (1,936)
Interest income 2,154 2,442
Loss before provision for income tax and equity in net earnings of equity investments (1,551,305) (2,019,428) (2,077,695) (3,068,619)
Provision for income tax (4,664) (16,791) (11,865) (63,624)
Loss before equity in net earnings of equity investments (1,555,969) (2,036,219) (2,089,560) (3,132,243)
Profit or (loss) on equity investment in China Joint Venture 15,460 (57,882) (28,941) (222,719)
Net loss (1,540,509) (2,094,101) (2,118,501) (3,354,962)
Net loss attributable to noncontrolling interests (61,684) (507,262) (134,808) (976,308)
Net loss attributable to Milestone Scientific Inc. $ (1,478,825) $ (1,586,839) $ (1,983,693) $ (2,378,654)
Net loss per share applicable to common stockholders—        
Basic (in dollars per share) $ (0.05) $ (0.06) $ (0.06) $ (0.10)
Diluted (in dollars per share) $ (0.05) $ (0.06) $ (0.06) $ (0.10)
Weighted average shares outstanding and to be issued—        
Basic (in shares) 32,399,997 25,989,857 32,122,482 24,362,441
Diluted (in shares) 32,399,997 25,989,857 32,122,482 24,362,441
Milestone China [Member]        
Revenue        
Product sales, net $ 356,400 $ 356,400 $ 1,714,600 $ 1,356,000
Profit or (loss) on equity investment in China Joint Venture $ 15,460 $ (57,882) $ 0 $ (164,837)